The office's primary duty is the implementation of 45CFR46, a set of regulations for Institutional Review Boards that directly mirrors the FDA regulation that covers clinical research conducted by pharmaceutical companies as well as other regulations under the aegis of the "common rule."
Institutions that conduct DHHS-sponsored research must have a "Federal-Wide Assurance" (FWA), an agreement with OHRP regarding ethical oversight. OHRP also provides education for IRBs, gives guidance on research ethics, and advises the Secretary on issues of medical ethics.